# Proteologics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/proteologics

- Industry: Biotechnology
- Headquarters: Rehovot, Israel
- Website: www.proteologics.com
- Total disclosed funding: $14M
- Latest round: Series A (Mar 1, 2001)
- Investors on record: 3

## About

Proteologics operates a digital asset management platform specializing in the staking of its native token, ADAO, allowing users to earn passive rewards while encouraging long-term investment in the cryptocurrency space.Proteologics is a digital asset management company headquartered in Rehovot, Israel. The company focuses on providing services around the staking of its native token, ADAO. In January 2010, Proteologics completed an IPO. The company has raised a total of USD 3.00 mn across 4 deals, with the latest round from Challenge Fund amounting to USD 3.00 mn.Proteologics.com primarily offers a digital asset management platform focused on the staking of its native token, ADAO. The core service enables users to earn passive rewards by holding and staking the ADAO token, which increases earning potential based on the duration of staking. This service incentivizes long-term investment and engagement, catering to individual investors, cryptocurrency enthusiasts, and institutional entities across North America, Europe, and parts of Asia.The revenue model of Proteologics.com is based on the staking of ADAO tokens, allowing users to earn rewards by locking their tokens on the platform. Transactions occur directly between the company and its clients, promoting a direct-to-consumer approach. Users stake their tokens for varying durations, which may lead to increased rewards, thereby enhancing user retention and participation. The primary engagement is through the staking service, which drives financial performance for the company.Proteologics plans to develop new features and enhancements to its platform, although specific products and release dates are not detailed. The company aims to expand into additional markets in Asia and Europe by 2024. The recent funding will support these initiatives, enhancing platform capabilities and increasing market presence. The most recent deal in January 2010 marked a strategic moment for the company as it positioned itself for future growth.

## Funding rounds

- Series A, Mar 1, 2001, $14M — Concord Ventures, Giza Venture Capital, ABS Ventures

## Investors

- Concord Ventures (https://capitalatlas.ai/funds/concord-ventures) — Series A
- Giza Venture Capital (https://capitalatlas.ai/funds/giza-venture-capital) — Series A
- ABS Ventures (https://capitalatlas.ai/funds/abs-ventures) — Series A